Biotechnologies and Genetics market in USA and Japan

compound, customer relationship management, dna chips, pipeline, venture capital, warrant, bioinformatics, biologics, biomarkers, biometrics, biotech, biotechnology, broadband, business models, business models, cancer, cell research, crm, customer relationship management, drug discovery, electronics, franchise, gene therapy, genetics, genomics, health insurance, healthcare, healthcare software, hospital, human cloning, human genome, infectious diseases, information technology, ingredient, insurers, internet connectivity, microarrays, microprocessor, monoclonal antibodies, monoclonal antibody, outsourcing, pharmaceutical, pharmaceuticals, proteomics, sclerosis, software, stem cell, toolbox, trading, venture capital,

index aging populations demands on healthcare innovation 45 47 amgen fipco strategy 123 125 antisense 122 asia biotechnology sector 153 154 160 165 asp application service provision 326 343 344 australia 166 bayh dole act 1980 107 betaseron beta interferon 113 biogen ripco business 128 129 bioinformatics databases 126 biologicals bioproducts see products biomarkers 62 successes and challenges 63 64 surrogate end points 69 companies for management 150 to 190 191 entrepreneurial 151 evolution 36 37 financing 41 interaction with other organizations 40 magnitude of resources required 152 managing periods financial stress mergers acquisitions 147 149 need culture flexibility ongoing rethinking models operational pharmaceutical company alliances 137 benefits both parties 139 143 bristol myers squibb deal imclone changing dynamic differences in ways doing 142 140 difficulties making work influence genomics technology 145 partial 144 what makes 27